Advanced Biomedical Research

The Interaction of Helicobacter pylori Infection and Type 2 Diabetes Mellitus

Reviewers

Authors

1 Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Biochemistry, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

Abstract

Helicobacter pylori is one of the most common human pathogens that can cause gastrointestinal (GI) disorders, including simple gastritis, gastric ulcer, and malignant gastritis. In some cases, such as immunodeficiency and underlying diseases, it can be problematic as opportunistic infections. Diabetes mellitus (type 2) (T2DM) is one of the H. pylori underlying diseases. Since GI problems are observed in diabetic patients, it is necessary to treat H. pylori infection. In this review, we aimed to evaluate the possible relationship between H. pylori and T2DM according to epidemiological surveys of 70 studies retrieved from databases, including Scopus, PubMed, and Google Scholar about the relationship between H. pylori and T2DM, and discuss the reported background mechanisms of this correlation. According to the results of our study, the different studies have shown that H. pylori is more prevalent in Type 2 diabetic patients than healthy individuals or nondiabetic patients. The reason is development of H. pylori infection-induced inflammation and production of inflammatory cytokines as well as different hormonal imbalance by this bacterium, which are associated with diabetes mellitus. On the other hand, by tracing anti-H. pylori antibodies in patients with diabetes mellitus and occurrence of symptoms such as digestive problems in >75% of these patients, it can be concluded that there is a relationship between this bacterium and T2DM. Considering the evidence, it is crucially important that the probability of infection with H. pylori is evaluated in patients with T2DM so that medical process of the patient is followed with higher cautious.

Keywords

1.
Marshall BJ, Warren JR. Unidentified curved bacilli in the stomach of patients with gastritis and peptic ulceration. Lancet 1984;1:1311-5.  Back to cited text no. 1
    
2.
Papamichael KX, Papaioannou G, Karga H, Roussos A, Mantzaris GJ. Helicobacter pylori infection and endocrine disorders: Is there a link? World J Gastroenterol 2009;15:2701-7.  Back to cited text no. 2
    
3.
Suerbaum S, Michetti P. Helicobacter pylori infection. N Engl J Med 2002;347:1175-86.  Back to cited text no. 3
    
4.
Khademi F, Faghri J, Poursina F, Esfahani BN, Moghim S, Fazeli H, et al. Resistance pattern of Helicobacter pylori strains to clarithromycin, metronidazole, and amoxicillin in Isfahan, Iran. J Res Med Sci 2013;18:1056-60.  Back to cited text no. 4
    
5.
Malfertheiner P, Chan FK, McColl KE. Peptic ulcer disease. Lancet 2009;374:1449-61.  Back to cited text no. 5
    
6.
Hosseini E, Poursina F, de Wiele TV, Safaei HG, Adibi P. Helicobacter pylori in Iran: A systematic review on the association of genotypes and gastroduodenal diseases. J Res Med Sci 2012;17:280-92.  Back to cited text no. 6
    
7.
Feldman R. Epidemiologic observations and open questions about disease and infection caused by Helicobacter pylori. In: Achtman M, Serbaum S, editors. Helicobacter pylori: Molecular and Cellular Biology. Uk: Horizon Scientific, 2001:29-51.  Back to cited text no. 7
    
8.
Malaty HM, Graham DY. Importance of childhood socioeconomic status on the current prevalence of Helicobacter pylori infection. Gut 1994;35:742-5.  Back to cited text no. 8
    
9.
Frenck RW Jr., Clemens J. Helicobacter in the developing world. Microbes Infect 2003;5:705-13.  Back to cited text no. 9
    
10.
Granquist A, Bredberg A, Sveger T, Axelsson I. A longitudinal cohort study on the prevalence of Helicobacter pylori antibodies in Swedish children and adolescents. Acta Paediatr 2002;91:636-40.  Back to cited text no. 10
    
11.
Rajashekhar V, Bhasin DK, Ray P, Vaiphei K, Sharma BC, Singh K, et al. Helicobacter pylori infection in chronic smokers with non ulcer dyspepsia. Trop Gastroenterol 2000;21:71-2.  Back to cited text no. 11
    
12.
Bakka AS, Salih BA. Prevalence of Helicobacter pylori infection in asymptomatic subjects in Libya. Diagn Microbiol Infect Dis 2002;43:265-8.  Back to cited text no. 12
    
13.
van Dieren S, Beulens JW, van der Schouw YT, Grobbee DE, Neal B. The global burden of diabetes and its complications: An emerging pandemic. Eur J Cardiovasc Prev Rehabil 2010;17 Suppl 1:S3-8.  Back to cited text no. 13
    
14.
He C, Yang Z, Lu NH. Helicobacter pylori infection and diabetes: Is it a myth or fact? World J Gastroenterol 2014;20:4607-17.  Back to cited text no. 14
    
15.
Agardh E, Allebeck P, Hallqvist J, Moradi T, Sidorchuk A. Type 2 diabetes incidence and socio-economic position: A systematic review and meta-analysis. Int J Epidemiol 2011;40:804-18.  Back to cited text no. 15
    
16.
Qi L, Hu FB, Hu G. Genes, environment, and interactions in prevention of Type 2 diabetes: A focus on physical activity and lifestyle changes. Curr Mol Med 2008;8:519-32.  Back to cited text no. 16
    
17.
Chen Y, Blaser MJ. Association between gastric Helicobacter pylori colonization and glycated hemoglobin levels. J Infect Dis 2012;205:1195-202.  Back to cited text no. 17
    
18.
Borody T, Ren Z, Pang G, Clancy R. Impaired host immunity contributes to Helicobacter pylori eradication failure. Am J Gastroenterol 2002;97:3032-7.  Back to cited text no. 18
    
19.
Jeon CY, Haan MN, Cheng C, Clayton ER, Mayeda ER, Miller JW, et al. Helicobacter pylori infection is associated with an increased rate of diabetes. Diabetes Care 2012;35:520-5.  Back to cited text no. 19
    
20.
de Luis DA, de la Calle H, Roy G, de Argila CM, Valdezate S, Canton R, et al. Helicobacter pylori infection and insulin-dependent diabetes mellitus. Diabetes Res Clin Pract 1998;39:143-6.  Back to cited text no. 20
    
21.
Gentile S, Turco S, Oliviero B, Torella R. The role of autonomic neuropathy as a risk factor of Helicobacter pylori infection in dyspeptic patients with Type 2 diabetes mellitus. Diabetes Res Clin Pract 1998;42:41-8.  Back to cited text no. 21
    
22.
Devrajani BR, Shah SZ, Soomro AA, Devrajani T. Type 2 diabetes mellitus: A risk factor for Helicobacter pylori infection: A hospital based case-control study. Int J Diabetes Dev Ctries 2010;30:22-6.  Back to cited text no. 22
    
23.
Bener A, Micallef R, Afifi M, Derbala M, Al-Mulla HM, Usmani MA, et al. Association between Type 2 diabetes mellitus and Helicobacter pylori infection. Turk J Gastroenterol 2007;18:225-9.  Back to cited text no. 23
    
24.
Gulcelik NE, Kaya E, Demirbas B, Culha C, Koc G, Ozkaya M, et al. Helicobacter pylori prevalence in diabetic patients and its relationship with dyspepsia and autonomic neuropathy. J Endocrinol Invest 2005;28:214-7.  Back to cited text no. 24
    
25.
Anastasios R, Goritsas C, Papamihail C, Trigidou R, Garzonis P, Ferti A, et al. Helicobacter pylori infection in diabetic patients: Prevalence and endoscopic findings. Eur J Intern Med 2002;13:376.  Back to cited text no. 25
    
26.
Ko GT, Chan FK, Chan WB, Sung JJ, Tsoi CL, To KF, et al. Helicobacter pylori infection in Chinese subjects with Type 2 diabetes. Endocr Res 2001;27:171-7.  Back to cited text no. 26
    
27.
Stanciu OG, Trifan A, Sfarti C, Cojocariu C, Stanciu C. Helicobacter pylori infection in patients with diabetes mellitus. Rev Med Chir Soc Med Nat Iasi 2003;107:59-65.  Back to cited text no. 27
    
28.
Parsonnet J, Shmuely H, Haggerty T. Fecal and oral shedding of Helicobacter pylori from healthy infected adults. JAMA 1999;282:2240-5.  Back to cited text no. 28
    
29.
Kozák R, Juhász E, Horvát G, Harcsa E, Lövei L, Sike R, et al. Helicobacter pylori infection in diabetic patients. Orv Hetil 1999;140:993-5.  Back to cited text no. 29
    
30.
El Hadidy M, Abdul-Aziz MY, Mokhtar AR, El Ata MM, El Gwad SS. Helicobacter pylori infection and vascular complications in patients with Type 2 diabetes mellitus. J Taibah Univ Med Sci 2009;4:62-72.  Back to cited text no. 30
    
31.
Shoelson SE, Lee J, Goldfine AB. Inflammation and insulin resistance. J Clin Invest 2006;116:1793-801.  Back to cited text no. 31
    
32.
Fernández-Real JM, López-Bermejo A, Vendrell J, Ferri MJ, Recasens M, Ricart W, et al. Burden of infection and insulin resistance in healthy middle-aged men. Diabetes Care 2006;29:1058-64.  Back to cited text no. 32
    
33.
Howard BV, Best L, Comuzzie A, Ebbesson SO, Epstein SE, Fabsitz RR, et al. C-reactive protein, insulin resistance, and metabolic syndrome in a population with a high burden of subclinical infection: Insights from the genetics of coronary artery disease in Alaska natives (GOCADAN) study. Diabetes Care 2008;31:2312-4.  Back to cited text no. 33
    
34.
Misiewicz JJ. Current insights in the pathogenesis of Helicobacter pylori infection. Eur J Gastroenterol Hepatol 1995;7:701-3.  Back to cited text no. 34
    
35.
Mishra RR, Tewari M, Shukla HS. Association of Helicobacter pylori infection with inflammatory cytokine expression in patients with gallbladder cancer. Indian J Gastroenterol 2013;32:232-5.  Back to cited text no. 35
    
36.
Diomedi M, Stanzione P, Sallustio F, Leone G, Renna A, Misaggi G, et al. Cytotoxin-associated gene-A-positive Helicobacter pylori strains infection increases the risk of recurrent atherosclerotic stroke. Helicobacter 2008;13:525-31.  Back to cited text no. 36
    
37.
Oshima T, Ozono R, Yano Y, Oishi Y, Teragawa H, Higashi Y, et al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects. J Am Coll Cardiol 2005;45:1219-22.  Back to cited text no. 37
    
38.
Jackson L, Britton J, Lewis SA, McKeever TM, Atherton J, Fullerton D, et al. Apopulation-based epidemiologic study of Helicobacter pylori infection and its association with systemic inflammation. Helicobacter 2009;14:108-13.  Back to cited text no. 38
    
39.
Hamed SA, Amine NF, Galal GM, Helal SR, Tag El-Din LM, Shawky OA, et al. Vascular risks and complications in diabetes mellitus: The role of Helicobacter pylori infection. J Stroke Cerebrovasc Dis 2008;17:86-94.  Back to cited text no. 39
    
40.
Wellen KE, Hotamisligil GS. Inflammation, stress, and diabetes. J Clin Invest 2005;115:1111-9.  Back to cited text no. 40
    
41.
Zojaji H, Ataei E, Sherafat SJ, Ghobakhlou M, Fatemi SR. The effect of the treatment of Helicobacter pylori infection on the glycemic control in Type 2 diabetes mellitus. Gastroenterol Hepatol Bed Bench 2013;6:36-40.  Back to cited text no. 41
    
42.
Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing Type 2 diabetes mellitus. JAMA 2001;286:327-34.  Back to cited text no. 42
    
43.
Barzilay JI, Abraham L, Heckbert SR, Cushman M, Kuller LH, Resnick HE, et al. The relation of markers of inflammation to the development of glucose disorders in the elderly: The cardiovascular health study. Diabetes 2001;50:2384-9.  Back to cited text no. 43
    
44.
Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, et al. Low-grade systemic inflammation and the development of Type 2 diabetes: The atherosclerosis risk in communities study. Diabetes 2003;52:1799-805.  Back to cited text no. 44
    
45.
Freeman DJ, Norrie J, Caslake MJ, Gaw A, Ford I, Lowe GD, et al. C-reactive protein is an independent predictor of risk for the development of diabetes in the west of Scotland coronary prevention study. Diabetes 2002;51:1596-600.  Back to cited text no. 45
    
46.
Hu FB, Meigs JB, Li TY, Rifai N, Manson JE. Inflammatory markers and risk of developing Type 2 diabetes in women. Diabetes 2004;53:693-700.  Back to cited text no. 46
    
47.
Thorand B, Löwel H, Schneider A, Kolb H, Meisinger C, Fröhlich M, et al. C-reactive protein as a predictor for incident diabetes mellitus among middle-aged men: Results from the MONICA Augsburg Cohort Study, 1984-1998. Arch Intern Med 2003;163:93-9.  Back to cited text no. 47
    
48.
Laaksonen DE, Niskanen L, Nyyssönen K, Punnonen K, Tuomainen TP, Valkonen VP, et al. C-reactive protein and the development of the metabolic syndrome and diabetes in middle-aged men. Diabetologia 2004;47:1403-10.  Back to cited text no. 48
    
49.
Festa A, D'Agostino R Jr., Tracy RP, Haffner SM; Insulin Resistance Atherosclerosis Study. Elevated levels of acute-phase proteins and plasminogen activator inhibitor-1 predict the development of Type 2 diabetes: The insulin resistance atherosclerosis study. Diabetes 2002;51:1131-7.  Back to cited text no. 49
    
50.
Han TS, Sattar N, Williams K, Gonzalez-Villalpando C, Lean ME, Haffner SM, et al. Prospective study of C-reactive protein in relation to the development of diabetes and metabolic syndrome in the Mexico City diabetes study. Diabetes Care 2002;25:2016-21.  Back to cited text no. 50
    
51.
Krakoff J, Funahashi T, Stehouwer CD, Schalkwijk CG, Tanaka S, Matsuzawa Y, et al. Inflammatory markers, adiponectin, and risk of Type 2 diabetes in the Pima Indian. Diabetes Care 2003;26:1745-51.  Back to cited text no. 51
    
52.
Snijder MB, Dekker JM, Visser M, Stehouwer CD, Yudkin JS, Bouter LM, et al. Prospective relation of C-reactive protein with Type 2 diabetes: Response to Han et al. Diabetes Care 2003;26:1656-7.  Back to cited text no. 52
    
53.
Markus HS, Risley P, Mendall MA, Steinmetz H, Sitzer M. Helicobacter pylori infection, the cytotoxin gene A strain, and carotid artery intima-media thickness. J Cardiovasc Risk 2002;9:1-6.  Back to cited text no. 53
    
54.
Aydemir S, Bayraktaroglu T, Sert M, Sokmen C, Atmaca H, Mungan G, et al. The effect of Helicobacter pylori on insulin resistance. Dig Dis Sci 2005;50:2090-3.  Back to cited text no. 54
    
55.
Gunji T, Matsuhashi N, Sato H, Fujibayashi K, Okumura M, Sasabe N, et al. Helicobacter pylori infection significantly increases insulin resistance in the asymptomatic Japanese population. Helicobacter 2009;14:144-50.  Back to cited text no. 55
    
56.
Gillum RF. Infection with Helicobacter pylori, coronary heart disease, cardiovascular risk factors, and systemic inflammation: The third national health and nutrition examination survey. J Natl Med Assoc 2004;96:1470-6.  Back to cited text no. 56
    
57.
Park SH, Jeon WK, Kim SH, Kim HJ, Park DI, Cho YK, et al. Helicobacter pylori eradication has no effect on metabolic and inflammatory parameters. J Natl Med Assoc 2005;97:508-13.  Back to cited text no. 57
    
58.
Jeffery PL, McGuckin MA, Linden SK. Endocrine impact of Helicobacter pylori: Focus on ghrelin and ghrelin o-acyltransferase. World J Gastroenterol 2011;17:1249-60.  Back to cited text no. 58
    
59.
Roper J, Francois F, Shue PL, Mourad MS, Pei Z, Olivares de Perez AZ, et al. Leptin and ghrelin in relation to Helicobacter pylori status in adult males. J Clin Endocrinol Metab 2008;93:2350-7.  Back to cited text no. 59
    
60.
Kaneko H, Konagaya T, Kusugami K. Helicobacter pylori and gut hormones. J Gastroenterol 2002;37:77-86.  Back to cited text no. 60
    
61.
So WY, Tong PC, Ko GT, Ma RC, Ozaki R, Kong AP, et al. Low plasma adiponectin level, white blood cell count and Helicobacter pylori titre independently predict abnormal pancreatic beta-cell function. Diabetes Res Clin Pract 2009;86:89-95.  Back to cited text no. 61
    
62.
Rahman MA, Cope MB, Sarker SA, Garvey WT, Chaudhury HS, Khaled MA, et al. Helicobacter pylori infection and inflammation: Implication for the pathophysiology of diabetes and coronary heart disease in Asian Indians. J Life Sci 2009;1:45-50.  Back to cited text no. 62
    
63.
Hsieh MC, Wang SS, Hsieh YT, Kuo FC, Soon MS, Wu DC, et al. Helicobacter pylori infection associated with high HbA1c and Type 2 diabetes. Eur J Clin Invest 2013;43:949-56.  Back to cited text no. 63
    
64.
Gen R, Demir M, Ataseven H. Effect of Helicobacter pylori eradication on insulin resistance, serum lipids and low-grade inflammation. South Med J 2010;103:190-6.  Back to cited text no. 64
    
65.
Calam J. Helicobacter pylori modulation of gastric acid. Yale J Biol Med 1999;72:195-202.  Back to cited text no. 65
    
66.
Osawa H, Nakazato M, Date Y, Kita H, Ohnishi H, Ueno H, et al. Impaired production of gastric ghrelin in chronic gastritis associated with Helicobacter pylori. J Clin Endocrinol Metab 2005;90:10-6.  Back to cited text no. 66
    
67.
Osawa H. Ghrelin and Helicobacter pylori infection. World J Gastroenterol 2008;14:6327-33.  Back to cited text no. 67
    
68.
Nishi Y, Isomoto H, Uotani S, Wen CY, Shikuwa S, Ohnita K, et al. Enhanced production of leptin in gastric fundic mucosa with Helicobacter pylori infection. World J Gastroenterol 2005;11:695-9.  Back to cited text no. 68
    
69.
Pöykkö SM, Kellokoski E, Hörkkö S, Kauma H, Kesäniemi YA, Ukkola O, et al. Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of Type 2 diabetes. Diabetes 2003;52:2546-53.  Back to cited text no. 69
    
70.
Cohen B, Novick D, Rubinstein M. Modulation of insulin activities by leptin. Science 1996;274:1185-8.  Back to cited text no. 70
    
71.
Segal KR, Landt M, Klein S. Relationship between insulin sensitivity and plasma leptin concentration in lean and obese men. Diabetes 1996;45:988-91.  Back to cited text no. 71
    
72.
Fischer S, Hanefeld M, Haffner SM, Fusch C, Schwanebeck U, Köhler C, et al. Insulin-resistant patients with Type 2 diabetes mellitus have higher serum leptin levels independently of body fat mass. Acta Diabetol 2002;39:105-10.  Back to cited text no. 72
    
73.
de Luis DA, Garcia Avello A, Lasuncion MA, Aller R, Martin de Argila C, Boixeda de Miquel D, et al. Improvement in lipid and haemostasis patterns after Helicobacter pylori infection eradication in Type 1 diabetic patients. Clin Nutr 1999;18:227-31.  Back to cited text no. 73
    
74.
Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, et al. Low grade inflammation and coronary heart disease: Prospective study and updated meta-analyses. BMJ 2000;321:199-204.  Back to cited text no. 74
    
75.
Sawayama Y, Ariyama I, Hamada M, Otaguro S, Machi T, Taira Y, et al. Association between chronic Helicobacter pylori infection and acute ischemic stroke: Fukuoka harasanshin atherosclerosis trial (FHAT). Atherosclerosis 2005;178:303-9.  Back to cited text no. 75
    
76.
Pietroiusti A, Diomedi M, Silvestrini M, Cupini LM, Luzzi I, Gomez-Miguel MJ, et al. Cytotoxin-associated gene-A – Positive Helicobacter pylori strains are associated with atherosclerotic stroke. Circulation 2002;106:580-4.  Back to cited text no. 76
    
77.
Schumacher A, Seljeflot I, Lerkerød AB, Sommervoll L, Otterstad JE, Arnesen H, et al. Positive chlamydia pneumoniae serology is associated with elevated levels of tumor necrosis factor alpha in patients with coronary heart disease. Atherosclerosis 2002;164:153-60.  Back to cited text no. 77
    
78.
Zito F, Di Castelnuovo A, D'Orazio A, Negrini R, De Lucia D, Donati MB, et al. Helicobacter pylori infection and the risk of myocardial infarction: Role of fibrinogen and its genetic control. Thromb Haemost 1999;82:14-8.  Back to cited text no. 78
    
Advanced Biomedical Research
Volume 2019, February
February 2019
Pages 1-6